MYCHELANGELO
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Jun 2025)
What this means for you
This application is over — abandoned 30 Jun 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97438108
- Mark type
- Stylized text
- Filed
- 01 Jun 2022
- Published for opposition
- 04 Apr 2023
- Abandoned
- 30 Jun 2025
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease; therapeutic pharmaceutical agents containing MYC inhibiting properties for the treatment of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease
- Class 042 — Scientific and technological services: Scientific research; pharmaceutical research services; medical research; technical scientific consulting services in the field of biotechnology; product development for others in the field of biotechnology; development of pharmaceutical preparations and medicines; research and development in the field of computational biology, bioinformatics, biotechnology and pharmaceuticals
Owner
- Omega Therapeutics, Inc., Cambridge, MA, US
- Omega Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 30 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Nov 2024 — SOU EXTENSION 3 GRANTED
- 26 Nov 2024 — SOU EXTENSION 3 FILED
- 26 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 29 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2024 — SOU EXTENSION 2 GRANTED
- 28 May 2024 — SOU EXTENSION 2 FILED
- 28 May 2024 — SOU TEAS EXTENSION RECEIVED
- 24 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Nov 2023 — SOU EXTENSION 1 GRANTED
- 22 Nov 2023 — SOU EXTENSION 1 FILED
- 22 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 01 Jun 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED